AU7098694A - Adoptive immune reconstitution treatment for patients with acquired immunodeficiencies - Google Patents

Adoptive immune reconstitution treatment for patients with acquired immunodeficiencies

Info

Publication number
AU7098694A
AU7098694A AU70986/94A AU7098694A AU7098694A AU 7098694 A AU7098694 A AU 7098694A AU 70986/94 A AU70986/94 A AU 70986/94A AU 7098694 A AU7098694 A AU 7098694A AU 7098694 A AU7098694 A AU 7098694A
Authority
AU
Australia
Prior art keywords
patients
immune reconstitution
adoptive immune
acquired immunodeficiencies
reconstitution treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU70986/94A
Inventor
Robert Howard Keller
William Mark Reiter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CENTER FOR SPECIAL IMMUNOLOGY
Original Assignee
CENTER SPECIAL IMMUNOLOGY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CENTER SPECIAL IMMUNOLOGY filed Critical CENTER SPECIAL IMMUNOLOGY
Publication of AU7098694A publication Critical patent/AU7098694A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/464838—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU70986/94A 1993-06-07 1994-06-07 Adoptive immune reconstitution treatment for patients with acquired immunodeficiencies Abandoned AU7098694A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7201393A 1993-06-07 1993-06-07
US072013 1993-06-07
PCT/US1994/006248 WO1994028934A1 (en) 1993-06-07 1994-06-07 Adoptive immune reconstitution treatment for patients with acquired immunodeficiencies

Publications (1)

Publication Number Publication Date
AU7098694A true AU7098694A (en) 1995-01-03

Family

ID=22105015

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70986/94A Abandoned AU7098694A (en) 1993-06-07 1994-06-07 Adoptive immune reconstitution treatment for patients with acquired immunodeficiencies

Country Status (2)

Country Link
AU (1) AU7098694A (en)
WO (1) WO1994028934A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6999096A (en) * 1995-09-25 1997-04-17 Samir Chachoua Use of 2-mercaptoethanolamine (2-mea) and related aminothiol compounds and copper(ii)-3,5 di-isopropyl salicylates and related compounds in the prevention and treatment of various diseases
US8354249B2 (en) * 2005-08-11 2013-01-15 Omrix Biopharmaceuticals Ltd. Intravenous immunoglobulin composition

Also Published As

Publication number Publication date
WO1994028934A1 (en) 1994-12-22

Similar Documents

Publication Publication Date Title
AU1966992A (en) Skin treatment system
AU640772B2 (en) Catheter for extracorporeal treatment
AU1873292A (en) Blood bag for lyophilization
AU7369191A (en) Medical diagnostic system
AU7338791A (en) Medical valve
AU2255195A (en) A medical article for implantation into the vascular system of a patient
AU2186792A (en) Patient sling
AU4048295A (en) Peptide medicaments for the treatment of disease
AU8737091A (en) Wheelchair
AU5457494A (en) Methods and procedures for preparing red blood fractions
AU4822993A (en) Subcutaneous implants based on nomegestrol derivatives
AU2954692A (en) Medical preparations
EP0448004A3 (en) Catheter for medical treatment
AU110010S (en) Medical trolley
AU5340594A (en) Skin treatment
AU7098694A (en) Adoptive immune reconstitution treatment for patients with acquired immunodeficiencies
AU6387994A (en) Device for medical treatment
AU7011098A (en) Treatment of adverse effects associated with administration of extracellular hemoglobin
AU1800195A (en) Durable patient chair
GB9217124D0 (en) Medical treatment
AU7982691A (en) Spinal traction beds
AU7239191A (en) Method for preventing immune suppression in trauma patients
EP0474406A3 (en) A rubber composition and a rubber article for pharmaceuticals and medical treatment
AU3977989A (en) Infrared videorefractometer particularly for application in pediatric ophthalmology
AU7968991A (en) Hospital bed